These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 18976762)

  • 1. Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis.
    Smith LP; Hacker MR; Alper MM
    Fertil Steril; 2009 Dec; 92(6):1953-9. PubMed ID: 18976762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Some aspects of ovarian hyperstimulation syndrome].
    Kovachev E; Kozovski I; Markova V; Andronov M; Cherneva S; Aleksandrov K
    Akush Ginekol (Sofiia); 2003; 42(6):37-41. PubMed ID: 15067814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Ross R; Morris S
    Fertil Steril; 2005 Jul; 84(1):93-8. PubMed ID: 16009163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of ascites up to 7.5 liters on one occasion and 45 liters in total may be safe in patients with severe ovarian hyperstimulation syndrome.
    Ozgun MT; Batukan C; Oner G; Uludag S; Aygen EM; Sahin Y
    Gynecol Endocrinol; 2008 Nov; 24(11):656-8. PubMed ID: 19031224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clinical characteristics between early and late patterns in hospitalized patients with ovarian hyperstimulation syndrome.
    Lee KH; Kim SH; Jee BC; Kim YJ; Suh CS; Kim KC; Lee WD
    Fertil Steril; 2010 May; 93(7):2274-80. PubMed ID: 19249755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oocyte quality in patients with severe ovarian hyperstimulation syndrome: a self-controlled clinical study.
    Fábregues F; Peñarrubia J; Vidal E; Casals G; Vanrell JA; Balasch J
    Fertil Steril; 2004 Oct; 82(4):827-33. PubMed ID: 15482755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
    Zhu WJ; Li XM; Chen XM; Zhang L
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Integral treatment of severe ovarian hyperstimulation syndrome by means of autotransfusion of ascitic fluid and intravenous infusion of albumin].
    Barrón Vallejo J; Pereyra Quiñones R; Esparza Iturbide JA; Kably Ambe A
    Ginecol Obstet Mex; 1998 Aug; 66():347-9. PubMed ID: 9745198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome.
    Várnagy A; Bódis J; Mánfai Z; Wilhelm F; Busznyák C; Koppán M
    Fertil Steril; 2010 May; 93(7):2281-4. PubMed ID: 19261278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of success during the coasting period in high-responder patients undergoing controlled ovarian stimulation for assisted conception.
    Ulug U; Ben-Shlomo I; Bahceci M
    Fertil Steril; 2004 Aug; 82(2):338-42. PubMed ID: 15302281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicted value of renin activity in a woman who had severe ovarian hyperstimulation syndrome with internal jugular vein thrombosis.
    Chang FW; Chan CC; Yin CS; Wu GJ
    Fertil Steril; 2004 Oct; 82(4):937-9. PubMed ID: 15482774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of cholestasis in the first trimester of pregnancy after ovarian hyperstimulation.
    Zamah AM; El-Sayed YY; Milki AA
    Fertil Steril; 2008 Oct; 90(4):1202.e7-10. PubMed ID: 18929050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-18 levels correlate with severe ovarian hyperstimulation syndrome.
    Barak V; Elchalal U; Edelstein M; Kalickman I; Lewin A; Abramov Y
    Fertil Steril; 2004 Aug; 82(2):415-20. PubMed ID: 15302292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum leptin concentrations in patients with severe ovarian hyperstimulation syndrome during in vitro fertilization-embryo transfer treatment.
    Ayustawati ; Shibahara H; Hirano Y; Suzuki T; Takamizawa S; Suzuki M
    Fertil Steril; 2004 Sep; 82(3):579-85. PubMed ID: 15374699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
    Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
    Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple transvaginal ascitic fluid aspirations improves the clinical and reproductive outcome in patients undergoing in vitro fertilisation treatment complicated by severe early ovarian hyperstimulation syndrome.
    Qublan HS; Al-Taani MI; Megdadi MF; Metri RM; Al-Ahmad N
    J Obstet Gynaecol; 2012 May; 32(4):379-82. PubMed ID: 22519486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ureteral injury after transvaginal ultrasound-guided oocyte retrieval: a complication of in vitro fertilization-embryo transfer that may lurk undetected in women presenting with severe ovarian hyperstimulation syndrome.
    Grynberg M; Berwanger AL; Toledano M; Frydman R; Deffieux X; Fanchin R
    Fertil Steril; 2011 Oct; 96(4):869-71. PubMed ID: 21839435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ounce of prevention: outpatient management of the ovarian hyperstimulation syndrome.
    Fluker MR; Copeland JE; Yuzpe AA
    Fertil Steril; 2000 Apr; 73(4):821-4. PubMed ID: 10731547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.